A COVID-vaccine maker received $1.6 billion in Operation Warp Speed funding. It’s administered just 7,300 shots in the U.S.

A COVID-vaccine maker received $1.6 billion in Operation Warp Speed funding. It’s administered just 7,300 shots in the U.S. Novavax’s jab only gained FDA approval in July and entered a saturated COVID-vaccine market. YahooFinance

...

Novavax CEO Stanley Erck blamed the company’s poor sales on a current glut of vaccine doses, leading governments to delay or suspend orders. Even COVAX, the international initiative to bring COVID vaccines to developing countries, has more vaccines than it needs right now. Erck told the Wall Street Journal that COVAX had walked away from an order of 350 million Novavax doses because of an oversupply from other manufacturers...